Literature DB >> 31792620

Current Update on Treatment Strategies for Idiopathic Normal Pressure Hydrocephalus.

Albert M Isaacs1,2, Michael A Williams3, Mark G Hamilton4,5.   

Abstract

PURPOSE OF REVIEW: Idiopathic normal pressure hydrocephalus (iNPH) is a surgically treatable neurological disorder of the elderly population that is characterized by abnormal ventricular enlargement due to cerebrospinal fluid (CSF) accumulation and gait disturbance, cognitive impairment, or urinary incontinence. The objective of this review is to present the current diagnostic and treatment approaches for iNPH and to discuss some of the postoperative modalities that complement positive surgical outcomes. RECENT
FINDINGS: Although historically reported patient outcomes following iNPH surgery were dismal and highly variable, recent advances in terms of better understanding of the iNPH disease process, better standardization of iNPH diagnostic and treatment processes arising from the adoption of clinical guidelines for diagnosis, treatment and in research methodologies, and availability of long-term follow-up data, have helped reduce the variations to a much improved 73 to 96% reported good outcomes. With careful evaluation, good patient selection, and advanced surgical techniques, iNPH can be surgically treated to return patients close to their pre-iNPH functional status. Institution of an interdisciplinary effort to rehabilitate patients following surgery may help augment their recovery.

Entities:  

Keywords:  Cerebrospinal fluid; Dementia; Hydrocephalus; Normal pressure hydrocephalus

Year:  2019        PMID: 31792620     DOI: 10.1007/s11940-019-0604-z

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  5 in total

Review 1.  The Pathogenesis Based on the Glymphatic System, Diagnosis, and Treatment of Idiopathic Normal Pressure Hydrocephalus.

Authors:  Changwu Tan; Xiaoqiang Wang; Yuchang Wang; Chuansen Wang; Zhi Tang; Zhiping Zhang; Jingping Liu; Gelei Xiao
Journal:  Clin Interv Aging       Date:  2021-01-15       Impact factor: 4.458

2.  Incidental findings of typical iNPH imaging signs in asymptomatic subjects with subclinical cognitive decline.

Authors:  Doortje C Engel; Lukas Pirpamer; Edith Hofer; Reinhold Schmidt; Cornelia Brendle
Journal:  Fluids Barriers CNS       Date:  2021-08-14

3.  A novel model of acquired hydrocephalus for evaluation of neurosurgical treatments.

Authors:  James P McAllister; Michael R Talcott; Albert M Isaacs; Sarah H Zwick; Maria Garcia-Bonilla; Leandro Castaneyra-Ruiz; Alexis L Hartman; Ryan N Dilger; Stephen A Fleming; Rebecca K Golden; Diego M Morales; Carolyn A Harris; David D Limbrick
Journal:  Fluids Barriers CNS       Date:  2021-11-08

Review 4.  Diagnosis and treatment for normal pressure hydrocephalus: From biomarkers identification to outcome improvement with combination therapy.

Authors:  Pao-Hui Tseng; Li-Kung Wu; Yi-Cheng Wang; Tsung-Jung Ho; Shinn-Zong Lin; Sheng-Tzung Tsai
Journal:  Tzu Chi Med J       Date:  2021-04-19

5.  Physical exercise and goal attainment after shunt surgery in idiopathic normal pressure hydrocephalus: a randomised clinical trial.

Authors:  Johanna Rydja; Lena Kollén; Per Hellström; Katarina Owen; Åsa Lundgren Nilsson; Carsten Wikkelsø; Mats Tullberg; Fredrik Lundin
Journal:  Fluids Barriers CNS       Date:  2021-11-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.